Seeking Alpha

stockhawk

stockhawk
Send Message
View as an RSS Feed
View stockhawk's Comments BY TICKER:
Latest  |  Highest rated
  • Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure [View article]
    Too late to short the damage is already done, and most of us former longs are out of the stock. Sorry, but at 8,9,10,11 or even 12 dollars you could have done well. Personally, it's too bad the AD results were a failure, it would have been good for the human race. Are you part of it? Hope you never get the disease.
    Apr 14 06:47 PM | 6 Likes Like |Link to Comment
  • VirnetX/Apple: What Does Apple Owe? [View article]
    Agreed, you could also factor in the of many traders maybe due to the need for a quick return or simply looking at trading as a "slot machine". It's amazing how the shorts control these stocks, even with the obvious potential. Could be partially explained by the patent troll label, and current administration's position on them. But the law is the law, IMO. Very well written and researched Tom, thanks.
    Mar 30 09:55 AM | 6 Likes Like |Link to Comment
  • Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors [View article]
    Jeff'c: interesting link to say the least. Good find.
    Mar 24 11:02 PM | 1 Like Like |Link to Comment
  • Vringo's Shareholder Update And What Investors Need To Know About Patent Reform And This Patent Hero [View article]
    StkT:From a long term holder/trader of vrng, litigation takes a long, long time. Kp sold out I think it was 75% of his position, so he has had enough of this. Don't expect to hear from him. He is smart, in that he cashed out, since the company,IMO, pays it's legal staff via various common share scenarios. Nothing wrong with that, since the SP valuation will come only when money is in the bank from their 2 sources of revenue, GOOG and ZTE. I learned that until the money is on the balance sheet, the valuation isn't either. That said, the legal team has done well in all their endeavours, so it's hard too fault them, once again, IMO.
    Mar 12 06:40 PM | 2 Likes Like |Link to Comment
  • Alzheimer's Research Stocks - Technical And Other Considerations [View article]
    I sure hope PRAN results are positive and then taken that way by the investment community. Their "roadshow" was intended to get publicity and the attention of Wall St., most certainly. Have traded the stock from 2.50 down to a dollar (holding), and then trading it up to 12, doing well along the way. Every time it seemed the best was over it comes back. Hope that wasn't the death knoll saying that! Anyway, hope the results come out soon and the news is good for all investors and all AD sufferers.
    Mar 8 11:15 PM | 1 Like Like |Link to Comment
  • Prana Biotechnology And MannKind Corp.: Bad News Obeys Its Own Special Laws [View article]
    Manoj, Two good articles, why on earth would they not be allowed to be published? Maybe SA should be renamed Seeking Shorts? No position in Mannkind, or plans to buy, full disclosure.
    Feb 22 08:10 AM | 2 Likes Like |Link to Comment
  • Vringo's Shareholder Update And What Investors Need To Know About Patent Reform And This Patent Hero [View article]
    If the share price holds above 5, for I believe it is 30 days, the warrants on the common become exercisable. As per the CC, this would result in 18 million more dollars, which could theoretically be on their balance sheet. At some point this may become a reality.
    Feb 15 09:31 AM | 3 Likes Like |Link to Comment
  • Where's The Next Billion-Dollar PAE Play? [View article]
    I listened to the call and thought the tone was okay, although no ADT numbers. The amount is probably small, or they would have brought it up. But I do agree with you that going forward things should get better. Patience really is a virtue. Happy to see so few comments, maybe the long term investors are finally here!
    Feb 13 06:15 PM | Likes Like |Link to Comment
  • Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment [View article]
    Congratulations on your investment. Had never followed Cadence, wish I had now. I did, however read one of your articles on Antares and was quite impressed with how in depth it was. Have been in ATRS for 2 years myself, albeit in a very small way, and also believe they will do well. It is a bit frustrating at the stock performance, but that doesn't mean the future isn't bright for them. Will look into DSCI simply out of respect for your work and reputation.
    Feb 13 05:39 PM | 5 Likes Like |Link to Comment
  • Vringo lower; Google, others withdraw motion to consolidate appeals [View news story]
    We all have one don't we (an opinion)? Mine is, after 2 years following this story, and listening to the CC from last night, the obvious is even more telling. Goog will continue to drag this out and hope for an executive decision (Obama), aka a pardon if you will, as the company vringo wins and wins. Or some kind of legislative relief that will weaken "patent trolls" and fatten the corporate white collar criminals. The call last night was informative and concise, and twice the low value given by the street was mentioned. 340 million dollar market cap for a company eventually owed 1 billion from one suit alone? They have 2 years worth of capital even without any revenue coming in. Listen to the call for yourselves. JMHO.
    Feb 13 05:19 PM | 2 Likes Like |Link to Comment
  • Phase II Results Approaching For Prana's PBT2 In Alzheimer's Dementia And Huntington's Disease [View article]
    Thanks for the reply. Aside from the volatility/ wide price swings we are currently seeing, a better understanding of the science helps. Awaiting any updates from the company and hoping PBT2 at least works to some degree.
    Feb 13 09:14 AM | 1 Like Like |Link to Comment
  • The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena [View article]
    For those in over their heads, if you believe in the management, don't be shaken out. This is the classic shake out. The weak hands sell at the first sign of weakness, and sell since they can't take the pressure. It is a garden variety way of life. If you know what you are doing, and are patient, no problem.
    Jan 27 08:34 PM | 3 Likes Like |Link to Comment
  • Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher [View article]
    Interesting. A small naked, long position is a good way to speculate IMO too. Been following for a couple of years and consider PBT2 a good risk since there are no drugs that work now on either disease, and with safety pretty much not a factor, up to this point, may some day be an ingredient in a cocktail? Even if many medical community folks don't believe in it, common sense says breaking down the metals from the plaque is a step in the right direction. Without risk, there would be no chance for a big upside. Appreciate the due diligence you put into story. Thanks.
    Jan 25 10:35 AM | 6 Likes Like |Link to Comment
  • Galena Biopharma -6.4% as Jim Cramer says take profits [View news story]
    RP I got the 78.4% from the November 2, 2013 A John Hodge story Five Reasons to Buy GALE. Definitely appreciate you're expertise on pharma and was mainly summarizing the positives going forward. I admit not knowing it all and am still learning.
    Jan 20 08:18 AM | Likes Like |Link to Comment
  • Galena Biopharma -6.4% as Jim Cramer says take profits [View news story]
    Cramer probably didn't do his dd on GALE. Very high institutional holdings, NeuVax 78% reduction in cancer in Phase II trial, 2012 Teva collaboration, combo trial with Roche's Herceptin in 2012, Abstral for cancer pain being marketed as we speak, and cash for 2 years out. I'm only summarizing. It certainly has had a great run, but for a reason. I still like it as do others.
    Jan 17 01:51 PM | 2 Likes Like |Link to Comment
COMMENTS STATS
220 Comments
245 Likes